As of the close on March 12, 2026, *ST Jingfeng (000908) closed at 4.81 yuan, an increase of 5.02%, with a turnover rate of 0.0%, a trading volume of 295.0 lots, and a transaction volume of 142,100 yuan.
Focus of the day
Transaction information summary fund flow
On March 12, the net inflow of main funds was 134,400 yuan; the net outflow of hot money was 48,100 yuan; the net outflow of retail funds was 86,300 yuan.
Summary of company announcements Morgan Stanley Securities (China) Co., Ltd.’s interim report on the trusteeship management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.’s public issuance of corporate bonds (first phase) to qualified investors in 2016
Hunan Jingfeng Pharmaceutical Co., Ltd. implemented the conversion of capital reserve funds into share capital. Based on the existing total share capital of 879,774,351 shares, 10 shares were converted for every 10 shares, resulting in a total of 879,774,351 shares. After the conversion, the total share capital increased to 1,759,548,702 shares. The registration date for this equity transfer is March 10, 2026, and the listing date for the equity transfer is March 11, 2026. The company's stock (securities abbreviation: *ST Jingfeng, stock code: 000908) will be suspended for one day from the market opening on March 10, 2026, and will resume trading from the market opening on March 11, 2026.
Morgan Stanley Securities (China) Co., Ltd.’s Interim Report on the Trusteeship of Hunan Jingfeng Pharmaceutical Co., Ltd.’s Public Issuance of Corporate Bonds to Qualified Investors in 2016 (First Phase)
Due to the implementation of the reorganization plan, Hunan Jingfeng Pharmaceutical Co., Ltd. converted its capital reserve to increase its share capital by converting 879,774,351 shares at a rate of 10 shares for every 10 shares. After the conversion, the total share capital increased to 1,759,548,702 shares. The reorganization investors paid RMB 2,060,857,594.18 in cash for the transferred shares, with an average price of RMB 2.34 per share. The equity registration date is March 10, 2026. The company's stock was suspended from trading on that day. The closing price was 6.37 yuan/share on the previous trading day, which was higher than the average transfer price. Therefore, the opening reference price on the next trading day was adjusted to 4.36 yuan/share. The company has entered the implementation stage of the reorganization plan. If the implementation fails, it will face the risk of being declared bankrupt and the stock being delisted.
The above content is compiled by Securities Star based on public information and generated by an AI algorithm (Network Information No. 310104345710301240019) and does not constitute investment advice.
